Heat Shock Proteins Accelerate the Maturation of Brain Endothelial Cell Glucocorticoid Receptor in Focal Human Drug-Resistant Epilepsy.


Journal

Molecular neurobiology
ISSN: 1559-1182
Titre abrégé: Mol Neurobiol
Pays: United States
ID NLM: 8900963

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 27 01 2020
accepted: 24 07 2020
pubmed: 5 8 2020
medline: 30 6 2021
entrez: 5 8 2020
Statut: ppublish

Résumé

Pharmacoresistance in epilepsy is a major challenge to successful clinical therapy. Glucocorticoid receptor (GR) dysregulation can affect the underlying disease pathogenesis. We recently reported that local drug biotransformation at the blood-brain barrier is upregulated by GR, which controls drug-metabolizing enzymes (e.g., cytochrome P450s, CYPs) and efflux drug transporters (MDR1) in human epileptic brain endothelial cells (EPI-ECs). Here, we establish that this mechanism is influenced upstream by GR and its association with heat shock proteins/co-chaperones (Hsps) during maturation, which differentially affect human epileptic (EPI) tissue and brain endothelial cells. Overexpressed GR, Hsp90, Hsp70, and Hsp40 were found in EPI vs. NON-EPI brain regions. Elevated neurovascular GR expression and co-localization with Hsps was evident in the EPI regions with cortical dysplasia, predominantly in the brain micro-capillaries and neurons. A corresponding increase in ATPase activity (*p < 0.05) was found in the EPI regions. The GR-Hsp90/Hsp70 binding patterns indicated a faster chaperone-promoted maturation of GR, leading to its overactivation in both the tissue and EPI-ECs derived from EPI/focal regions and GR silencing in EPI-ECs slowed such GR-Hsp interactions. Significantly accelerated GR nuclear translocation was determined in EPI-ECs following treatment with GR modulators/ligands dexamethasone, rifampicin, or phenytoin. Our findings reveal that overexpressed GR co-localizes with Hsps in the neurovasculature of EPI brain, increased GR maturation by Hsps accelerates EPI GR machinery, and furthermore this change in EPI and NON-EPI GR-Hsp interaction alters with the age of seizure onset in epileptic patients, together affecting the pathophysiology and drug regulation in the epileptic brain endothelium.

Identifiants

pubmed: 32748370
doi: 10.1007/s12035-020-02043-9
pii: 10.1007/s12035-020-02043-9
pmc: PMC7530040
mid: NIHMS1617575
doi:

Substances chimiques

ABCB1 protein, human 0
ATP Binding Cassette Transporter, Subfamily B 0
Heat-Shock Proteins 0
Receptors, Glucocorticoid 0
Phenytoin 6158TKW0C5
Cytochrome P-450 Enzyme System 9035-51-2
Adenosine Triphosphatases EC 3.6.1.-
Oxcarbazepine VZI5B1W380

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4511-4529

Subventions

Organisme : NHLBI NIH HHS
ID : R56 HL139564
Pays : United States
Organisme : NINDS NIH HHS
ID : R01NS078307
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS078307
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS095825
Pays : United States
Organisme : NINDS NIH HHS
ID : R01NS095825
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL150049
Pays : United States
Organisme : National Heart, Lung, and Blood Institute/National Institute of Health
ID : R56HL139564

Références

Epilepsia. 2017 Apr;58(4):576-585
pubmed: 28199000
Anal Biochem. 1997 Nov 15;253(2):162-8
pubmed: 9367498
Nature. 2003 Sep 25;425(6956):407-10
pubmed: 14508491
Trends Pharmacol Sci. 2013 Sep;34(9):518-30
pubmed: 23953592
Epilepsia. 2001 Dec;42(12):1501-6
pubmed: 11879359
Epilepsia. 2015 Mar;56(3):439-49
pubmed: 25656284
Mol Cell. 1998 Jun;1(7):959-68
pubmed: 9651579
Transl Psychiatry. 2018 Mar 1;8(1):53
pubmed: 29491368
Cell Mol Life Sci. 2014 Jul;71(13):2499-515
pubmed: 24522255
N Engl J Med. 2011 Sep 8;365(10):919-26
pubmed: 21899452
Nat Rev Cancer. 2005 Oct;5(10):761-72
pubmed: 16175177
J Cereb Blood Flow Metab. 2015 Jul;35(7):1191-8
pubmed: 25757751
J Exp Med. 2017 Feb;214(2):547-563
pubmed: 28028152
FASEB J. 2019 Sep;33(9):9885-9896
pubmed: 31170354
Mol Neurobiol. 2019 Dec;56(12):8392-8407
pubmed: 31243719
Drug Discov Today. 2016 Oct;21(10):1609-1619
pubmed: 27312874
Epilepsia. 2018 Nov;59(11):2049-2060
pubmed: 30264400
Epilepsia. 2011 Mar;52(3):562-71
pubmed: 21294720
F1000Res. 2017 Jul 24;6:1208
pubmed: 28781762
Neuroscience. 2013;255:265-77
pubmed: 24096135
Ann N Y Acad Sci. 2006 Jun;1069:1-9
pubmed: 16855130
Proc Natl Acad Sci U S A. 2012 Aug 7;109(32):12998-3003
pubmed: 22837396
Epilepsia. 2007 Mar;48(3):505-16
pubmed: 17326793
Mol Cell Endocrinol. 2013 Nov 5;380(1-2):41-54
pubmed: 23267834
Mol Neurobiol. 2019 Jul;56(7):4904-4915
pubmed: 30414085
J Neurochem. 2008 Dec;107(5):1335-46
pubmed: 18808451
PLoS One. 2018 Feb 7;13(2):e0191270
pubmed: 29415049
Pharm Res. 2014 Jun;31(6):1588-604
pubmed: 24477677
Cell. 2014 Jun 19;157(7):1685-97
pubmed: 24949977
J Neurochem. 2006 Aug;98(4):1176-84
pubmed: 16895583
Mol Cell Endocrinol. 2007 Sep 15;275(1-2):2-12
pubmed: 17628337
Neurobiol Aging. 2013 Jun;34(6):1662-73
pubmed: 23290588
Biotechniques. 2002 Mar;32(3):636-8, 640, 642 passim
pubmed: 11911666
Drug Discov Today. 2020 Jan;25(1):89-106
pubmed: 31541713
Mol Cell Biol. 2006 Nov;26(22):8385-95
pubmed: 16982694
Expert Rev Neurother. 2009 Dec;9(12):1791-802
pubmed: 19951138
Cell Tissue Res. 2014 Mar;355(3):597-605
pubmed: 24352805
Epilepsy Res. 2011 Jun;95(1-2):20-34
pubmed: 21439793
Trends Endocrinol Metab. 2001 Apr;12(3):122-6
pubmed: 11306337
J Clin Invest. 2017 Apr 3;127(4):1136-1145
pubmed: 28319043
PLoS One. 2015 Mar 10;10(3):e0120538
pubmed: 25756665
FASEB J. 2011 Jun;25(6):2049-60
pubmed: 21357526
J Clin Invest. 2005 Jan;115(1):177-86
pubmed: 15630458
Epilepsia. 2014 Nov;55(11):1834-43
pubmed: 25244257
Neurobiol Dis. 2012 Jun;46(3):692-700
pubmed: 22426401
J Biol Chem. 1993 Oct 15;268(29):21455-8
pubmed: 8407992
Ann Neurol. 1998 Oct;44(4):584-91
pubmed: 9778256
J Pharmacol Exp Ther. 2009 Apr;329(1):141-9
pubmed: 19147857
Epilepsia. 2010 Aug;51(8):1408-17
pubmed: 20074231
Epilepsia. 2009 Apr;50(4):664-77
pubmed: 19175391

Auteurs

Mohammed Hossain (M)

Cerebrovascular Research, Department of Biomedical Engineering, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.

Sherice Williams (S)

Cerebrovascular Research, Department of Biomedical Engineering, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.

Lisa Ferguson (L)

Epilepsy Center, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA.

William Bingaman (W)

Epilepsy Center, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA.

Arnab Ghosh (A)

Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.

Imad M Najm (IM)

Epilepsy Center, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA.

Chaitali Ghosh (C)

Cerebrovascular Research, Department of Biomedical Engineering, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA. GHOSHC@ccf.org.
Department of Biomedical Engineering and Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA. GHOSHC@ccf.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH